Maternal Risk Factors Associated with Inadequate Testing and Loss to Follow-up in Infants with Perinatal Hepatitis C Virus Exposure

1694. Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland Magnus Gottfredsson, MD, PhD; Thorarinn Tyrfingsson, MD; Valgerdur Runarsdottir, MD; Ottar M. Bergmann, MD; Einar S. Bjornsson, MD, PhD; Birgir Johannsson, MD; Bryndis Sigurdardottir, MD; Ragnheidur H. Fridriksdottir, RN, MBA; Arthur Löve, MD, PhD; Thorvardur J. Löve, MD, PhD; Gudrun Sigmundsdottir, MD, PhD; Maria Heimisdottir, MD, PhD, MBA; Sigurdur Olafsson, MD; Infectious Diseases, Landspitali University Hospital, Reykjavik, Iceland; Vogur Hospital, Reykjavik, Iceland; Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland; Virology, Landspitali University Hospital, Reykjavik, Iceland; Science, Landspitali University Hospital, Reykjavik, Iceland; State Epidemiologist, Directorate of Health, Reykjavik, Iceland; Finance, Landspitali University Hospital, Reykjavik, Iceland